Pharmacogenomics: Data and Innovation to Deliver Precise and Appropriate Medication Use

This new, free 60-minute webinar will help you understand the impact of pharmacogenomics (PGx) in prescription prescribing and evaluate the technical challenges and limitations associated with scaling it. The session will also explore PGx solutions that can be easily implemented in your laboratory.

As pharmacogenomic (PGx) testing becomes more familiar for its role in the refinement of treatment(s) to reduce risk of adverse responses and improve efficacy of medications, clinicians, clinical laboratory directors and managers, and pharmacists will have questions about how to work with and scale PGx (and other high-value molecular testing). 

One molecular testing laboratory has found success with rapid integration of its software engagement tools for medication therapy management (MTM)—including genotype-guided recommendations for drug selection and dosing—into the EMR of major hospitals. 

In this webinar, from Dark Daily, brings Jeremy Stuart, PhD, MPH (NRCC), Chief Science Officer and Laboratory Director at Precision Genetics, describes the development of the software tools that proved essential for the scaling of molecular testing at South Carolina-based Precision Genetics. Stuart explains how digital integration essential to scaling their COVID-19 testing efforts has positioned the lab to expand operations to deliver effective pharmacogenetic-based guidance to providers in the areas of psychiatry and perioperative medicine.